These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND IGK
99 results:

  • 1. EXPRESSION OF IMMUNOGLOBULIN LIGHT CHAIN GENES IN STEREOTYPED CASES FROM UKRAINIAN COHORT OF CHRONIC LYMPHOCYTIC leukemia PATIENTS.
    Abramenko I; Bilous N; Martina Z; Dyagil I; Chumak A
    Exp Oncol; 2024 Dec; 46(3):202-208. PubMed ID: 39704461
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression Cloning of Antibodies from Single Human B Cells.
    Rollenske T; Murugan R; Wardemann H; Busse CE
    Methods Mol Biol; 2025; 2865():103-124. PubMed ID: 39424722
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clonotypic VDJ Rearrangements in Mixed Phenotype Acute leukemia can be Successfully Utilized to Track Minimal Residual Disease.
    Hennawi M; Quadeer F; Pakasticali N; Osman S; Tashkandi H; Hussaini MO
    Appl Immunohistochem Mol Morphol; 2024 Aug; 32(7):305-308. PubMed ID: 38695552
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
    Quesada AE; Hu S; Li S; Toruner GA; Wei Q; Loghavi S; Ok CY; Jain P; Thakral B; Nwogbo OV; Kim D; Iyer SP; You MJ; Medeiros LJ; Tang G
    Hum Pathol; 2024 Feb; 144():71-76. PubMed ID: 38301962
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL.
    Chen H; Gu M; Liang J; Song H; Zhang J; Xu W; Zhao F; Shen D; Shen H; Liao C; Tang Y; Xu X
    Nat Commun; 2023 Nov; 14(1):7468. PubMed ID: 37978187
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
    Leongamornlert D; Gutiérrez-Abril J; Lee S; Barretta E; Creasey T; Gundem G; Levine MF; Arango-Ossa JE; Liosis K; Medina-Martinez JS; Zuborne Alapi K; Kirkwood AA; Clifton-Hadley L; Patrick P; Jones D; O'Neill L; Butler AP; Harrison CJ; Campbell P; Patel B; Moorman AV; Fielding AK; Papaemmanuil E
    Blood Adv; 2023 Aug; 7(15):3862-3873. PubMed ID: 36867579
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia.
    Mai H; Li Q; Wang G; Wang Y; Liu S; Tang X; Chen F; Zhou G; Liu Y; Li T; Wang L; Wang C; Wen F; Liu S
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3259-3266. PubMed ID: 35918464
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. One-Step Next-Generation Sequencing of Immunoglobulin and T-Cell Receptor Gene Recombinations for MRD Marker Identification in Acute Lymphoblastic leukemia.
    Villarese P; Abdo C; Bertrand M; Thonier F; Giraud M; Salson M; Macintyre E
    Methods Mol Biol; 2022; 2453():43-59. PubMed ID: 35622319
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Combinatorial CAR design improves target restriction.
    Köksal H; Dillard P; Juzeniene A; Kvalheim G; Smeland EB; Myklebust JH; Inderberg EM; Wälchli S
    J Biol Chem; 2021; 296():100116. PubMed ID: 33234592
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CAR T cells targeting options in the fight against multiple myeloma.
    Nicolini F; Bravaccini S; Mazza M; Gruszka AM; Tazzari M; MartÍn-Antonio B; Juan M; Ibrahim T; Maltoni R; Martinelli G; Cerchione C
    Panminerva Med; 2021 Mar; 63(1):37-45. PubMed ID: 32955187
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
    Della Starza I; De Novi LA; Cavalli M; Novelli N; Soscia R; Genuardi E; Mantoan B; Drandi D; Ferrante M; Monitillo L; Barbero D; Ciabatti E; Grassi S; Bomben R; Degan M; Gattei V; Galimberti S; Di Rocco A; Martelli M; Cortelazzo S; Guarini A; Foà R; Ladetto M; Ferrero S; Del Giudice I;
    Hematol Oncol; 2020 Dec; 38(5):698-704. PubMed ID: 32816326
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.
    Ching T; Duncan ME; Newman-Eerkes T; McWhorter MME; Tracy JM; Steen MS; Brown RP; Venkatasubbarao S; Akers NK; Vignali M; Moorhead ME; Watson D; Emerson RO; Mann TP; Cimler BM; Swatkowski PL; Kirsch IR; Sang C; Robins HS; Howie B; Sherwood A
    BMC Cancer; 2020 Jun; 20(1):612. PubMed ID: 32605647
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS.
    Scheijen B; Meijers RWJ; Rijntjes J; van der Klift MY; Möbs M; Steinhilber J; Reigl T; van den Brand M; Kotrová M; Ritter JM; Catherwood MA; Stamatopoulos K; Brüggemann M; Davi F; Darzentas N; Pott C; Fend F; Hummel M; Langerak AW; Groenen PJTA;
    Leukemia; 2019 Sep; 33(9):2227-2240. PubMed ID: 31197258
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Histiocytic Sarcoma Following B-Lymphoblastic leukemia/Lymphoma.
    Geyer JT; Yigit N; Miyaguchi A; Cheng S; Casano J; Mathew S; Desai P; Gergis U; Tam W
    Am J Clin Pathol; 2019 Sep; 152(4):486-494. PubMed ID: 31172191
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression Cloning of Antibodies from Single Human B Cells.
    Wardemann H; Busse CE
    Methods Mol Biol; 2019; 1956():105-125. PubMed ID: 30779032
    [TBL] [Abstract] [Full Text] [Related]  

  • 17.
    Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
    Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia.
    Jo I; Chung NG; Lee S; Kwon A; Kim J; Choi H; Jang W; Kim S; Lee JW; Yoon JH; Cho B; Han K; Kim Y; Kim M
    Clin Chim Acta; 2019 Jan; 488():81-89. PubMed ID: 30389459
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Next-generation antigen receptor sequencing of paired diagnosis and relapse samples of B-cell acute lymphoblastic leukemia: Clonal evolution and implications for minimal residual disease target selection.
    Theunissen PMJ; de Bie M; van Zessen D; de Haas V; Stubbs AP; van der Velden VHJ
    Leuk Res; 2019 Jan; 76():98-104. PubMed ID: 30389174
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Richter's syndrome of the central nervous system diagnosed concurrently with chronic lymphocytic leukaemia: A case report and literature review.
    Xu L; Song JC; Sun XH; Gao ZF; Lv L; Zhu J
    Medicine (Baltimore); 2018 Oct; 97(41):e12701. PubMed ID: 30313065
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 5.